The global Plasma Vaporization Electrode Market is projected to experience a revenue compound annual growth rate (CAGR) of 7.8% during the forecast period from 2022 to 2030. The primary driver of this growth is the increasing prevalence of prostate cancer worldwide. According to the American Cancer Society, approximately 1 in 9 men will be diagnosed with prostate cancer in their lifetime, and the number of cases has been steadily rising in recent years. This trend is expected to continue, leading to a higher demand for plasma vaporization electrodes and subsequently driving the market's revenue growth.
Furthermore, ongoing technological advancements from leading industry players are expected to substantially bolster revenue expansion. The debut of enhanced plasma vaporization electrodes has heightened the procedure's effectiveness and efficiency, resulting in increased acceptance among a broader patient population. As a result, there is an anticipated rise in the number of procedures conducted, which will continue to propel market revenue growth throughout the projected period.
Get a free sample PDF of the report, visit @ https://www.reportsanddata.com/download-free-sample/5243
However, one of the major obstacles to revenue growth in the market is the high cost of the procedure. Plasma vaporization electrodes are more expensive than conventional electrodes used in transurethral resection of the prostate (TURP) procedures. As a result, many patients find the procedure unaffordable. Additionally, a lack of awareness among patients about available procedures and treatments could also hinder market revenue growth to some extent.
The trend of opting for minimally invasive procedures is gaining popularity among patients and doctors alike. These procedures are less painful and have shorter recovery times, making them more attractive. This increased preference for minimally invasive procedures is expected to drive demand for plasma vaporization electrodes in the forecast period. Additionally, the number of clinical trials conducted for this procedure is on the rise, contributing to greater awareness and further driving market revenue growth.
The global market is segmented by product type, application, end use, and region. In terms of product type, the market is divided into monopolar and bipolar electrodes. The bipolar segment is expected to achieve the highest revenue CAGR during the forecast period. Bipolar electrodes offer superior performance compared to monopolar electrodes, providing better cutting and coagulation while minimizing tissue injury. They also have shorter procedure times and require less anesthesia, which increases their demand.
Based on application, the market is segmented into transurethral resection of the prostate (TURP), transurethral incision of the prostate (TUIP), transurethral microwave thermotherapy (TUMT), and trans-urethral needle ablation (TUNA). The TURP segment is projected to account for the largest revenue share in the global market throughout the forecast period. This is due to the high number of procedures performed for this indication, as TURP is considered the gold standard treatment for benign prostatic hyperplasia (BPH) and has been widely used for many years.
To know more about the latest insights of the report, visit @
https://www.reportsanddata.com/request-latest-insight/5243
By end use, the market is segmented into hospitals, clinics, and ambulatory surgical centers (ASCs). The hospitals segment is expected to hold the largest revenue share in the global market during the forecast period. This is primarily because a greater number of procedures are performed in hospitals compared to other healthcare facilities. Hospitals possess the necessary infrastructure and trained personnel to perform these procedures effectively.
Geographically, the North America market is anticipated to account for the largest revenue share in the global market during the forecast period. This is attributed to the high prevalence of prostate cancer in the region and the availability of advanced healthcare facilities. The European market is expected to register a significantly high revenue growth rate, primarily due to the increasing number of clinical trials being conducted in countries within this region. Meanwhile, the Asia Pacific market is projected to experience the fastest revenue growth rate globally during the forecast period, driven by the rising prevalence of prostate cancer and increasing patient awareness about this new surgical option.
In terms of the competitive landscape, key players in this market include Boston Scientific Corporation, Cook Medical, Inc., BK Ultrasound, Inc., Olympus Corporation, and Lumenis Ltd. These companies have implemented various strategies to enhance their market position. For example, in September 2019, Boston Scientific Corporation acquired Apama Medical, Inc., expanding its product portfolio and strengthening its market presence. Similarly, Cook Medical, Inc. launched a new plasma vaporization electrode for the treatment of BPH in January 2018, aiming to provide superior performance and improved patient outcomes. Additionally, Lumenis Ltd. introduced a new plasma vaporization system for BPH treatment in May 2017, designed to deliver enhanced performance and better patient outcomes.
In summary, the global plasma vaporization electrode market is expected to witness substantial growth during the forecast period, driven by factors such as the increasing prevalence of prostate cancer, continuous technological advancements, and the preference for minimally invasive procedures. While the high cost of the procedure and lack of patient awareness pose challenges, the market is poised to benefit from the superior performance of bipolar electrodes and the strong presence of hospitals in performing these procedures. North America is projected to lead in terms of revenue share, with Europe and Asia Pacific also experiencing significant growth. Key market players continue to implement strategies to enhance their market position and offer improved solutions to patients.
Request a customized copy of the report @ https://www.reportsanddata.com/request-customization-form/5243
Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.
Browse for more reports:
Electronic Lab Notebook (ELN) Market
Epilepsy Monitoring Devices Market
Erectile Dysfunction (ED) Drug Market
Fabry Disease Treatment Market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
